BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
RESEARCH & DEVELOPMENT: Agricultural biotechnology: Application of plant biotechnology to improve the
energy content, essential amino acids, protein and fiber composition of corn
and oilseeds for animal nutrition. Use biotechnology to improve crop
processing (for example, oil and starch processing, meal, ethanol and
biodiesel production)
Corn processing technology: Pilot plant under construction will test
processing technologies that extract the trait value of the new Mavera high
value corn. The technology is expected to make ethanol manufacturing
more profitable and to provide the opportunity for farmers to grow net
revenue enhancing crops on broad acres.
PRODUCTS ON MARKET: Mavera program for growers and animal producers
Renovo Group plc
The Manchester Incubator Building, 48 Grafton Street
Manchester M13 9XX, UK
Phone: +44 (0) 161 606 7222; Fax: +44 (0) 161 606 7333
Web: www.renovo.com
E-mail: info@renovo.com
KEY PERSONNEL: Rodger Pannone; Chairman
Prof. Mark Ferguson; CEO
Dr. Sharon O’Kane, Exec. Director, R&D
Andrew Kay; Exec. Director, Commercial
Robin Cridland; Exec. Director, Finance and Business Development
EMPLOYEES: 100 employees
HISTORY: Founded in October 2000
STOCK-FINANCIAL HISTORY: LSE--RNVO
IPO--87p/share, £50M
PRIVATE PLACEMENTS: Raised £21M (US$33M) in financing (12/02)
Raised £2M (US$3.2M) in over-subscription to its second round of financing
(1/03)
PRINCIPAL INVESTORS: Atlas Venture
BioVeda Capital (Pte.) Ltd.
Care Capital LLC
HealthCap
JPMorgan Partners
Temasek
BUSINESS STRATEGY: Leverage extensive scientific knowledge to develop commercial product
candidates in scar prevention and reduction
Be first-to-market with a pharmaceutical product to prevent and reduce
scarring
Continue to advance and expand the company's clinical and preclinical
pipeline
Extend the significant market potential for the company's lead product
candidates to multiple body sites and fibrotic disorders
Pursue a commercialization strategy working with partners to increase
speed and depth of market penetration
RESEARCH & DEVELOPMENT: Prevention and reduction of scarring throughout the body, including skin,
vascular restenosis, eyes, nerves, adhesions and strictures, tendons and
ligaments, fibrotic disorders
Copyright ©2006 AHC Media ® 340